Bellerophon Therapeutics Inc (NASDAQ: BLPH) was a top gainer in yesterday’s trading session. The stock rallied to reverse several months of losses, and close the day with gains of 163.37%. This came after the company announced positive topline data on acute, intra-patient, dose increase in the PHPF-002...
Assertio Therapeutics Inc (NASDAQ: ASRT) was a top gainer on Friday, after closing the day with gains of 46.15%. This came after the company announced that, it had entered into an agreement with Collegium for the sale of its NUCYNTA franchise. Under the deal,...
Genprex Inc. (NASDAQ: GNPX) maintained upside momentum in yesterday’s session, and closed the day with gains of 23.44%. This came after news that, independent researchers had found the company’s TUSC2 to be a possible novel biomarker for treating thyroid cancer. The results found that, the overexpression of...
Moderna Inc (NASDAQ: MRNA) like a host of other biotech stocks was in the green in yesterday’s session. This was driven by investor speculation on companies that are looking into Coronavirus. In yesterday’s session, MRNA rallied to close the day with gains of 7.67% on a day...
The year 2019 was a mixed bag for IPOs. One of the company’s that went public and has performed well is OneConnect Financial Technology Ltd (NYSE: OCFT). The company went public in December, at $10 and rallied to a high of $16.60. Yesterday, it closed the day...
Apellis Pharmaceuticals Inc (NASDAQ: APLS) made significant gains in yesterday’s trading session, as it closed the day with gains of 28.29%. This followed several major announcements both in science and finance. On the scientific front, the company announced that it had positive results from its...
Inpixon (NASDAQ: INPX) was one of the top gainers in the New Year. It rallied in the day by 201.83%, to close the day at $0.33. This came after the company gave a recap of 2019, and offered insights into 2020. The company noted that, 2019 was...
BioXcel Therapeutics Inc (NASDAQ: BTAI) made a new high in yesterday’s session, and closed the day with gains of 40.35%. This followed the company’s announcement that it had started its Sub-Lingual Dexmedetomidine in Agitation Associated with Schizophrenia and Bipolar disorder study (SERENITY) program. The two-phase studies are...
CLPS Incorporation (NASDAQ: CLPS) was one of the top gainers just ahead of Christmas. The stock rallied to close the day with gains of 47.13%. This came after it announced that, it had completed the integration of Infogain Pte Ltd and RidKik Pte Ltd into its Singapore...
Catalyst BioSciences Inc (NASDAQ: CBIO) was one of the top gainers in yesterday’s trading session, and closed the day with gains of 65.83%. This came after it announced that, it had entered into a global license and collaboration with Biogen Inc.  The agreement between the two companies...